首页> 外国专利> INJECTABLE STERILE AQUEOUS FORMULATION BASED ON CROSSLINKED HYALURONIC ACID AND ON HYDROXYAPATITE, FOR THERAPEUTIC USE.

INJECTABLE STERILE AQUEOUS FORMULATION BASED ON CROSSLINKED HYALURONIC ACID AND ON HYDROXYAPATITE, FOR THERAPEUTIC USE.

机译:基于交联透明质酸和羟基磷灰石的可注射无菌水制剂,用于治疗用途。

摘要

The subject matter of the present invention is a ready-to-use, resorbable, injectable, sterile aqueous formulation used for therapeutic purposes, in the form of a particulate cohesive viscoelastic gel comprising i) crosslinked hyaluronic acid, or a salt thereof, at a concentration of between 1% and 4% (weight/volume), the crosslinking carried out making it possible to obtain a crosslinked hyaluronic acid-based gel having a structure termed cohesive, and ii) hydroxyapatite, at a concentration of between 10% and 70% (weight/volume), said hydroxyapatite being in the form of particles having an average size of less than or equal to 650 µm; wherein said injectable sterile aqueous formulation has viscoelastic properties such that Tanδ at the frequency of 1 Hz is less than or equal to 0.60.
机译:本发明的主题是用于治疗目的的即用的,可吸收的,可注射的,无菌的水性制剂,其为包含i)交联的透明质酸或其盐的颗粒内聚粘弹性凝胶的形式。浓度为1%至4%(重量/体积)的情况下,进行交联可得到一种交联的透明质酸基凝胶,该凝胶具有被称为内聚的结构,并且ii)羟基磷灰石的浓度在10%至70之间%(重量/体积),所述羟基磷灰石为平均尺寸小于或等于650 µm的颗粒形式;其中所述注射用无菌水性制剂具有粘弹性质,使得Tanα在1 Hz频率下小于或等于0.60。

著录项

  • 公开/公告号MX2015004165A

    专利类型

  • 公开/公告日2015-10-14

    原文格式PDF

  • 申请/专利权人 APTISSEN S.A.;

    申请/专利号MX20150004165

  • 发明设计人 SAMUEL GAVARD MOLLIARD;

    申请日2013-09-24

  • 分类号A61K9;A61K6/838;A61K6/898;A61K31/728;A61K33/42;A61P41;

  • 国家 MX

  • 入库时间 2022-08-21 15:13:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号